| 日期 | 內部人 | 職稱 | 代碼 | 股數 | 價格 | 金額 |
|---|---|---|---|---|---|---|
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | 10% Owner | P | 700,000 | – | – |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | 10% Owner | S | 7,966,667 | – | – |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | 10% Owner | J | 400,000 | – | – |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | 10% Owner | P | 700,000 | – | – |
| Sep 26, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | P | 70,000 | – | – |
| Sep 26, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | S | 7,966,667 | – | – |
| Sep 26, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | J | 400,000 | – | – |
| Sep 26, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | P | 700,000 | – | – |
| Sep 26, 2025 | Prasad Sridhar G. | Director | J | 100,000 | – | – |
| Sep 26, 2025 | Worman Glenn C. | CFO | J | 100,000 | – | – |
| Sep 26, 2025 | Shulgan Myron W. | Director | J | 100,000 | – | – |
| Sep 26, 2025 | Do Catherine | Director | J | 100,000 | – | – |